Skip to main navigation Skip to search Skip to main content

In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface

  • Christopher Davis
  • , Helen J Harris
  • , Ke Hu
  • , Heidi Edelgard Drummer
  • , Jane A McKeating
  • , Jonathan G L Mullins
  • , Peter Balfe

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Hepatitis C virus (HCV) entry is dependent on host cell molecules tetraspanin CD81, scavenger receptor BI and tight junction proteins claudin-1 and occludin. We previously reported a role for CD81/claudin-1 receptor complexes in HCV entry; however, the molecular mechanism(s) driving association between the receptors is unknown. We explored the molecular interface between CD81 and claudin-1 using a combination of bioinformatic sequence-based modelling, site-directed mutagenesis and Fluorescent Resonance Energy Transfer (FRET) imaging methodologies. Structural modelling predicts the first extracellular loop of claudin-1 to have a flexible beta conformation and identifies a motif between amino acids 62-66 that interacts with CD81 residues T149, E152 and T153. FRET studies confirm a role for these CD81 residues in claudin-1 association and HCV infection. Importantly, mutation of these CD81 residues has minimal impact on protein conformation or HCV glycoprotein binding, highlighting a new functional domain of CD81 that is essential for virus entry.
Original languageEnglish
Pages (from-to)1892 - 1903
Number of pages12
JournalCellular Microbiology
Volume14
Issue number12
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this